Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
3882.19%
↑ 1276% above average
Average (39q)
282.14%
Historical baseline
Range
High:3882.19%
Low:-107.69%
Volatility
1414.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 3882.19% |
| Q2 2025 | -107.69% |
| Q1 2025 | 1154.44% |
| Q4 2024 | -104.64% |
| Q3 2024 | 126.14% |
| Q2 2024 | 53.58% |
| Q1 2024 | -94.99% |
| Q4 2023 | 922.20% |
| Q3 2023 | 293.50% |
| Q2 2023 | -57.97% |
| Q1 2023 | -89.44% |
| Q4 2022 | -42.20% |
| Q3 2022 | 2246.74% |
| Q2 2022 | 54.36% |
| Q1 2022 | -15.34% |
| Q4 2021 | -37.14% |
| Q3 2021 | -0.18% |
| Q2 2021 | -2.43% |
| Q1 2021 | 95.58% |
| Q4 2020 | 13.08% |
| Q3 2020 | -60.43% |
| Q2 2020 | 376.09% |
| Q1 2020 | 102.94% |
| Q4 2019 | -56.69% |
| Q3 2019 | -95.03% |
| Q2 2019 | 39.66% |
| Q1 2019 | 1315.00% |
| Q4 2018 | -63.22% |
| Q3 2018 | -82.57% |
| Q2 2018 | 1552.32% |
| Q1 2018 | -38.37% |
| Q4 2017 | 6.06% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |